Parkinson's (medication)

I know this can be a terribly debilitating condition, and though I welcome the progress that has been made in tackling it over recent years, more must be done.

The use of medication plays a vital role in the delivery of high quality care, particularly in the case of treatment for Parkinson's disease.
Processes for delivering and administering medication to patients are becoming more complex and often involve multiple steps. This, alongside changes to drug delivery methods, increases in the number of prescribed medications per patient, and number of patients assigned to each nurse, has impacted medication administration times. Hospitals are currently tasked with, and held accountable to, administering medications within 30 minutes before or after the scheduled time.

I therefore welcome the NHS 5-year funding plan which will see a further £33.9 billion invested into the NHS over the period. This money will help to increase staff numbers; in turn, this will reduce the pressure on staff distributing medicines.

I welcome the Parkinson's UK 'Get It On Time' report and support all steps to improve care in this area. I also fully support the collaboration between Parkinson's UK and the Care and Quality Commission to train and implement best practice and believe that bringing health professionals, people with Parkinson's and now regulators together to find a way to further improve care is critical.

I understand that the National Institute for Health and Care Excellence (NICE) has recently updated its guidance on the diagnosis, treatment and management of Parkinson's disease. These new guidelines will ensure that people with Parkinson's are able to access the best possible care and treatment in order to manage their condition effectively.